<?xml version="1.0" encoding="ISO-8859-1"?>
<!DOCTYPE ichicsr SYSTEM "icsr-xml-v2.1.dtd">
<ichicsr lang="en">
    <ichicsrmessageheader>
        <messagetype>ichicsr</messagetype>
        <messageformatversion>2.1</messageformatversion>
        <messageformatrelease>2.0</messageformatrelease>
        <messagenumb>UCBPHAPROD-92320-320690</messagenumb>
        <messagesenderidentifier>UCBPVGPRD</messagesenderidentifier>
        <messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
        <messagedateformat>204</messagedateformat>
        <messagedate>20130125161659</messagedate>
    </ichicsrmessageheader>
    <safetyreport>
        <safetyreportversion>1</safetyreportversion>
        <safetyreportid>US-UCBSA-075976</safetyreportid>
        <primarysourcecountry>US</primarysourcecountry>
        <occurcountry>US</occurcountry>
        <transmissiondateformat>102</transmissiondateformat>
        <transmissiondate>20130125</transmissiondate>
        <reporttype>1</reporttype>
        <serious>1</serious>
        <seriousnessdeath>1</seriousnessdeath>
        <receivedateformat>102</receivedateformat>
        <receivedate>20130116</receivedate>
        <receiptdateformat>102</receiptdateformat>
        <receiptdate>20130116</receiptdate>
        <additionaldocument>2</additionaldocument>
        <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
        <companynumb>US-UCBSA-075976</companynumb>
        <medicallyconfirm>2</medicallyconfirm>
        <primarysource>
            <reportergivename>Privacy</reportergivename>
            <reportercountry>US</reportercountry>
            <qualification>5</qualification>
        </primarysource>
        <sender>
            <sendertype>1</sendertype>
            <senderorganization>UCB</senderorganization>
            <sendertitle>Dr.</sendertitle>
            <sendergivename>Peter</sendergivename>
            <senderfamilyname>Verdru</senderfamilyname>
            <senderstreetaddress>1950 Lake Park Drive</senderstreetaddress>
            <sendercity>Smyrna</sendercity>
            <senderstate>GA</senderstate>
            <senderpostcode>30080</senderpostcode>
            <sendercountrycode>US</sendercountrycode>
            <sendertel>9197673193</sendertel>
            <sendertelcountrycode>1</sendertelcountrycode>
            <senderfax>9197673174</senderfax>
            <senderfaxcountrycode>1</senderfaxcountrycode>
            <senderemailaddress>peter.verdru@ucb.com</senderemailaddress>
        </sender>
        <receiver>
            <receivertype>2</receivertype>
            <receiverorganization>FDA</receiverorganization>
            <receiverdepartment>Office of Surveillance and Epidemiology</receiverdepartment>
            <receivertitle>Mr.</receivertitle>
            <receivergivename>Roger</receivergivename>
            <receiverfamilyname>Goetsch</receiverfamilyname>
            <receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
            <receivercity>Landover</receivercity>
            <receiverstate>MD</receiverstate>
            <receiverpostcode>20785</receiverpostcode>
            <receivercountrycode>US</receivercountrycode>
            <receivertel>3019189580</receivertel>
            <receivertelextension>194</receivertelextension>
            <receivertelcountrycode>1</receivertelcountrycode>
            <receiverfax>3019183134</receiverfax>
            <receiverfaxcountrycode>1</receiverfaxcountrycode>
            <receiveremailaddress>roger.goetsch@fda.hhs.gov</receiveremailaddress>
        </receiver>
        <patient>
            <patientinitial>JE</patientinitial>
            <patientbirthdateformat>102</patientbirthdateformat>
            <patientbirthdate>19550601</patientbirthdate>
            <patientonsetage>55</patientonsetage>
            <patientonsetageunit>801</patientonsetageunit>
            <patientsex>1</patientsex>
            <patientdeath>
                <patientdeathdateformat>102</patientdeathdateformat>
                <patientdeathdate>20100604</patientdeathdate>
                <patientautopsyyesno>3</patientautopsyyesno>
                <patientdeathcause>
                    <patientdeathreportmeddraversion>15.1</patientdeathreportmeddraversion>
                    <patientdeathreport>Death</patientdeathreport>
                </patientdeathcause>
            </patientdeath>
            <reaction>
                <primarysourcereaction>PASSED AWAY</primarysourcereaction>
                <reactionmeddraversionllt>15.1</reactionmeddraversionllt>
                <reactionmeddrallt>10011906</reactionmeddrallt>
                <reactionmeddraversionpt>15.1</reactionmeddraversionpt>
                <reactionmeddrapt>10011906</reactionmeddrapt>
                <reactionstartdateformat>102</reactionstartdateformat>
                <reactionstartdate>20100604</reactionstartdate>
                <reactionenddateformat>102</reactionenddateformat>
                <reactionenddate>20100604</reactionenddate>
                <reactionduration>1</reactionduration>
                <reactiondurationunit>804</reactiondurationunit>
                <reactionoutcome>5</reactionoutcome>
            </reaction>
            <drug>
                <drugcharacterization>1</drugcharacterization>
                <medicinalproduct>VIMPAT</medicinalproduct>
                <drugauthorizationnumb>22-253</drugauthorizationnumb>
                <drugdosagetext>STRENGTH: 100MG</drugdosagetext>
                <drugdosageform>Tablet</drugdosageform>
                <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
                <drugindication>Convulsion</drugindication>
                <actiondrug>6</actiondrug>
                <activesubstance>
                    <activesubstancename>LACOSAMIDE</activesubstancename>
                </activesubstance>
            </drug>
            <drug>
                <drugcharacterization>1</drugcharacterization>
                <medicinalproduct>KEPPRA</medicinalproduct>
                <drugdosagetext>DOSE STRENGTH:500MG</drugdosagetext>
                <drugdosageform>Tablet</drugdosageform>
                <drugindicationmeddraversion>15.1</drugindicationmeddraversion>
                <drugindication>Convulsion</drugindication>
                <actiondrug>6</actiondrug>
                <activesubstance>
                    <activesubstancename>LEVETIRACETAM</activesubstancename>
                </activesubstance>
            </drug>
            <summary>
                <narrativeincludeclinical>This spontaneous fatal case was received by UCB from a consumer (patient's wife) on 16-Jan-2013. 

This report concerns a 55-year-old male patient from the United States of America.
 
On an unknown date, the patient was initiated on Vimpat (lacosamide) 100mg tablet and co-suspect drug Keppra (levetiracetam) 500mg tablet for the treatment of seizures.

On 04-Jun-2010, the patient passed away.

The cause of death was not reported and it was unknown if an autopsy was performed.</narrativeincludeclinical>
                <sendercomment>Consumer report. Adult male patient died after an unknown duration of exposure to lacosamide and levetiracetam (co-suspect drug). Cause of death was not reported. Unknown if an autopsy was performed.</sendercomment>
            </summary>
        </patient>
    </safetyreport>
</ichicsr>